TY - JOUR
T1 - The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger
AU - Han, Chan H.
AU - Lu, Jiachun
AU - Wei, Qingyi
AU - Bondy, Melissa L.
AU - Brewster, Abenaa M.
AU - Yu, Tse Kuan
AU - Buchholz, Thomas A.
AU - Arun, Banu K.
AU - Wang, Li E.
N1 - Funding Information:
Acknowledgments This study was supported in part by National Institutes of Health Grants R03 CA108364 (L.E.W.), P50 CA116199 (H.G.), R01 ES011740, and R01 CA131274 (Q.W.), and P30 CA016672 (M. D. Anderson Cancer Center). We thank Margaret Lung for her assistance in recruiting the subjects; Yawei Qiao, Kejing Xu, Zhensheng Liu, Jianzhong He, and Yinyan Li for their laboratory assistance.
PY - 2010/7
Y1 - 2010/7
N2 - PIN1, an isomerase that causes conformational changes in proteins, plays an important role in mammary epithelial cell growth both physiologically and pathologically. Thus, genetic variants in the PIN1 gene may alter protein function and cancer risk. We have previously demonstrated an association between a PIN1 promoter variant (-842G>C; rs2233678) and risk of squamous cell carcinoma of the head and neck, a finding supported by additional functional data. In the present study, we genotyped two promoter single nucleotide polymorphisms (SNPs) (-842G>C, rs2233678 and -667T>C, rs2233679) and one synonymous SNP (Gln33Gln; G>A, rs2233682) in exon 2 to evaluate their associations with risk of sporadic breast cancer in non-Hispanic white women 55 years and younger. We found that the carriers of -842C variant alleles had decreased risk of breast cancer with an adjusted odd ratio (OR) of 0.67 and 95% confidence interval (CI) of 0.50-0.90. This reduced risk was more evident in women after reproductive age of 45 (OR = 0.63, 95% CI = 0.42-0.93), ever-smokers (OR = 0.56, 95% CI = 0.36-0.88), and ever-drinkers (OR = 0.67, 95% CI = 0.45-0.99). No such associations were observed for PIN1 -667T>C and PIN1 Gln33Gln. However, the haplotypes of these three SNPs were also associated with reduced risk of breast cancer. In conclusion, the PIN1 polymorphisms may contribute to the etiology of sporadic breast cancer in non-Hispanic white women 55 years and younger. Further validation in large population-based studies is needed.
AB - PIN1, an isomerase that causes conformational changes in proteins, plays an important role in mammary epithelial cell growth both physiologically and pathologically. Thus, genetic variants in the PIN1 gene may alter protein function and cancer risk. We have previously demonstrated an association between a PIN1 promoter variant (-842G>C; rs2233678) and risk of squamous cell carcinoma of the head and neck, a finding supported by additional functional data. In the present study, we genotyped two promoter single nucleotide polymorphisms (SNPs) (-842G>C, rs2233678 and -667T>C, rs2233679) and one synonymous SNP (Gln33Gln; G>A, rs2233682) in exon 2 to evaluate their associations with risk of sporadic breast cancer in non-Hispanic white women 55 years and younger. We found that the carriers of -842C variant alleles had decreased risk of breast cancer with an adjusted odd ratio (OR) of 0.67 and 95% confidence interval (CI) of 0.50-0.90. This reduced risk was more evident in women after reproductive age of 45 (OR = 0.63, 95% CI = 0.42-0.93), ever-smokers (OR = 0.56, 95% CI = 0.36-0.88), and ever-drinkers (OR = 0.67, 95% CI = 0.45-0.99). No such associations were observed for PIN1 -667T>C and PIN1 Gln33Gln. However, the haplotypes of these three SNPs were also associated with reduced risk of breast cancer. In conclusion, the PIN1 polymorphisms may contribute to the etiology of sporadic breast cancer in non-Hispanic white women 55 years and younger. Further validation in large population-based studies is needed.
KW - Breast cancer
KW - Genetic susceptibility
KW - Molecular epidemiology
KW - PIN1
UR - http://www.scopus.com/inward/record.url?scp=77953535030&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953535030&partnerID=8YFLogxK
U2 - 10.1007/s10549-009-0682-9
DO - 10.1007/s10549-009-0682-9
M3 - Article
C2 - 20033770
AN - SCOPUS:77953535030
SN - 0167-6806
VL - 122
SP - 243
EP - 249
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 1
ER -